Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones

详细信息    查看全文

• 作者：Daphne de Bruin ; Igle J. de Jong ; Eugè ; ne G.J.M. Arts ; Janine Nuver ; Robin P.F. Dullaart ; Willem J. Sluiter ; Harald J. Hoekstra ; Dirk T. Sleijfer ; Jourik A. Gietema
• 关键词：Testicular cancer ; spermatogenesis ; β ; -hCG ; pituitary gonadal hormones
• 刊名：Fertility and Sterility
• 出版年：2009
• 出版时间：June 2009
• 年：2009
• 卷：91
• 期：6
• 页码：2481-2486
• 全文大小：139 K

文摘

Objective

To compare the semen quality and hormonal status between patients with testicular cancer and normal versus increased serum levels of β-hCG.

Design

Retrospective study.

Setting

Academic research environment.

Patient(s)

All 203 patients with testicular cancer who required chemotherapy in the period 1995–2003 were included.

Intervention(s)

In 107 patients semen samples were stored by cryopreservation; 62 patients could be analyzed because both semen was stored and hormones were determined before starting chemotherapy (median age 25 years, range 17–49 years).

Main Outcome Measure(s)

Total motile sperm count, T, E₂, LH, FSH, and PRL.

Result(s)

Total motile sperm count was decreased in patients with increased β-hCG (median 11.9 × 10⁶) compared with patients with normal β-hCG (median 21.5 × 10⁶). Testosterone, E₂, and PRL were significantly higher in patients with increased β-hCG levels, whereas LH and FSH were lower. Semen quality was significantly and negatively correlated with β-hCG, E₂, and PRL.

Conclusion(s)

Patients with increased β-hCG had an inferior spermatogenesis compared with patients with normal β-hCG. Increased β-hCG appears to be associated with impaired spermatogenesis and increased levels of E₂ and PRL.